Renalytix reported a gross margin of 19.16% and a net margin of -905.75% for the quarter ended Sep 2024. These financial ratios cover 19 quarters of results from Jun 2018 through Sep 2024, standardized by Business Quant from the company’s SEC filings.
| RatiosRatios | Jun2018 | Jun2019 | Jun2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||
| Gross Margin | 35.75% | 72.70% | 8.47% | 52.90% | 41.78% | 15.64% | 16.73% | 28.17% | 40.35% | 16.71% | -29.92% | -9.37% | 32.30% | -12.34% | 6.14% | 19.16% | |||
| EBT Margin | -2,153.25% | -1,303.88% | -2,082.42% | -2,096.68% | -1,813.25% | -1,809.73% | -617.09% | -1,233.64% | -876.17% | -1,672.24% | -2,142.86% | -2,212.20% | -1,196.19% | -1,447.29% | -1,207.17% | -905.36% | |||
| EBIT Margin | -2,153.25% | -1,303.88% | -2,082.42% | -2,451.04% | -1,631.01% | -1,790.27% | -1,570.40% | -1,209.70% | -809.40% | -1,507.87% | -1,917.76% | -1,936.60% | -1,218.76% | -1,224.86% | -942.83% | -784.10% | |||
| EBITDA Margin | -2,140.25% | -1,291.44% | -2,061.23% | -2,426.35% | -1,618.34% | -1,774.51% | -1,554.15% | -1,196.28% | -798.66% | -1,489.92% | -1,894.59% | -1,908.93% | -1,203.53% | -1,211.96% | -932.59% | -772.61% | |||
| Operating Margin | -2,153.25% | -1,303.88% | -2,082.42% | -2,451.04% | -1,631.01% | -1,790.27% | -1,570.40% | -1,209.70% | -809.40% | -1,507.87% | -1,917.76% | -1,936.60% | -1,218.76% | -1,224.86% | -942.83% | -784.10% | |||
| Net Margin | -2,227.00% | -1,417.77% | -2,080.51% | -2,096.68% | -1,813.25% | -1,809.73% | -620.10% | -1,233.54% | -876.17% | -1,672.10% | -2,143.63% | -2,212.20% | -1,196.76% | -1,447.29% | -1,207.17% | -905.75% | |||
| FCF Margin | -787.88% | -1,057.42% | -2,222.82% | -1,693.49% | -905.42% | -1,697.35% | -734.67% | -690.60% | -1,395.17% | -1,666.60% | -2,070.59% | -1,116.93% | -908.79% | -1,335.67% | -734.87% | ||||
| Efficiency | |||||||||||||||||||
| Assets AverageAssets Avg. | 4.91M | 15.29M | 49.41M | 47.27M | 44.39M | 34.69M | 35.23M | 35.22M | 25.08M | 15.41M | 10.02M | 8.37M | 6.38M | ||||||
| Equity AverageEquity Avg. | 4.02M | 12.23M | 51.40M | 83.46M | 75.74M | 65.72M | 52.89M | 37.61M | 30.01M | 24.73M | 13.86M | 13.49M | 12.53M | 2.74M | -4.72M | -9.53M | -9.48M | -9.59M | |
| Invested CapitalInvested Cap. | -0.06M | 16.17M | 35.27M | 23.32M | 13.48M | 22.57M | 11.43M | 3.08M | -4.89M | -6.66M | -3.70M | -7.18M | |||||||
| Asset Utilization RatioAsset Util. | 0.05 | 0.06 | 0.08 | 0.11 | 0.11 | 0.10 | 0.12 | 0.16 | 0.22 | 0.27 | 0.37 | ||||||||
| Leverage & Solvency | |||||||||||||||||||
| Debt Ratio | 3.81 | 0.01 | 0.09 | 0.12 | 0.15 | 0.11 | 0.15 | 0.23 | 0.27 | 0.51 | 0.52 | 0.86 | |||||||
| Valuation | |||||||||||||||||||
| Price to SalesP/S | 0.23M | 0.15M | 0.06M | 0.02M | 0.01M | 0.01M | 0.02M | 0.03M | 0.02M | 0.01M | 0.01M | 0.00M | 0.00M | ||||||
| Price to BookP/B | 0.00M | 0.01M | 0.01M | 0.01M | 0.01M | 0.01M | 0.00M | 0.00M | 0.00M | 0.00M | 0.01M | ||||||||
| Enterprise Value | 297,080.67M | 476,443.12M | 696,187.45M | 452,361.12M | 358,690.34M | 156,094.23M | 57,197.12M | 29,925.70M | 43,741.11M | 70,889.22M | 86,680.56M | 48,701.18M | 12,173.37M | 26,240.07M | 7,804.77M | 6,902.19M | |||
| Market Capitalization | 297,080.67M | 476,443.12M | 696,252.58M | 452,361.12M | 358,730.26M | 156,126.63M | 57,238.46M | 29,956.74M | 43,764.92M | 70,922.24M | 86,705.24M | 48,715.08M | 12,178.99M | 26,244.77M | 7,809.47M | 6,903.10M | |||
| Return Ratios | |||||||||||||||||||
| Return on Sales [ROS]ROS | -2,153.25% | -1,303.88% | -2,082.42% | -2,451.04% | -1,631.01% | -1,790.27% | -1,570.40% | -1,209.70% | -809.40% | -1,507.87% | -1,917.76% | -1,936.60% | -1,218.76% | -1,224.86% | -942.83% | -784.10% | |||
| Return on Capital Employed [ROCE]ROCE | -145.35% | -149.86% | -170.96% | -239.99% | -220.65% | -221.29% | -397.40% | -2,582.84% | |||||||||||
| Return on Invested Capital [ROIC]ROIC | -181.25% | -266.14% | -251.56% | -248.36% | -542.98% | ||||||||||||||
| Return on Assets [ROA]ROA | -101.09% | -95.79% | -106.16% | -121.80% | -112.57% | -129.51% | -174.64% | -271.61% | -374.02% | -399.69% | -439.14% | ||||||||
| Return on Equity [ROE]ROE | -55.72% | -81.93% | -132.82% | -150.86% | -190.60% | -304.72% | -293.96% | -363.94% | -1,600.00% |
Pull Renalytix's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=RNLXY&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "RNLXY", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=RNLXY&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();